Balyasny Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Balyasny Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.87M	Sell	3,800 -23,000	-86%	-$12.5M	﹤0.01%	1810
2025 Q4	$15.5M	Buy	26,800 +21,900	+447%	+$12.4M	0.02%	849
2025 Q3	$2.38M	Buy	4,900 +2,800	+133%	+$1.3M	﹤0.01%	1724
2025 Q2	$851K	Sell	2,100 -44,000	-95%	-$18.4M	﹤0.01%	2097
2025 Q1	$22.9M	Buy	46,100 +33,300	+260%	+$18M	0.04%	545
2024 Q4	$6.66M	Buy	12,800 +10,700	+510%	+$5.88M	0.01%	1136
2024 Q3	$1.3M	Sell	2,100 -4,200	-67%	-$2.49M	﹤0.01%	1862
2024 Q2	$3.48M	Buy	6,300 +5,400	+600%	+$3.09M	0.01%	1331
2024 Q1	$523K	Sell	900 -1,200	-57%	-$673K	﹤0.01%	2030
2023 Q4	$1.11M	Buy	2,100 +1,600	+320%	+$774K	﹤0.01%	1642
2023 Q3	$253K	Sell	500 -12,500	-96%	-$6.66M	﹤0.01%	1970
2023 Q2	$6.78M	Buy	+13,000	New	+$7.02M	0.01%	950
2022 Q2	–	Sell	-14,000	Closed	-$8.27M	–	3183
2022 Q1	$8.27M	Buy	+14,000	New	+$8.04M	0.03%	759
2021 Q3	–	Sell	-1,700	Closed	-$858K	–	2426
2021 Q2	$858K	Buy	+1,700	New	+$802K	﹤0.01%	1355
2020 Q4	–	Sell	-10,000	Closed	-$4.42M	–	1697
2020 Q3	$4.42M	Buy	+10,000	New	+$4.13M	0.03%	649
2020 Q2	–	Sell	-30,000	Closed	-$8.51M	–	1483
2020 Q1	$8.51M	Buy	+30,000	New	+$9.46M	0.1%	277
2019 Q3	–	Sell	-15,000	Closed	-$4.42M	–	1589
2019 Q2	$4.42M	Sell	15,000 -21,000	-58%	-$5.78M	0.03%	643
2019 Q1	$9.85M	Buy	+36,000	New	+$8.96M	0.07%	389
2016 Q3	–	Sell	-30,000	Closed	-$4.43M	–	1266
2016 Q2	$4.43M	Buy	+30,000	New	+$4.43M	0.03%	533

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Balyasny Asset Management's TMO Position: Q1 2026 in Review

Balyasny Asset Management increased its Thermo Fisher Scientific (TMO) stake by 6,432% in Q1 2026, buying an estimated $297M and bringing the position to 555,473 shares worth $273M. The position accounts for 0.35% of the portfolio, ranked #39.

Balyasny Asset Management first reported a position in TMO in Q2 2013 and has held it in 37 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Balyasny Asset Management held 555,473 shares of Thermo Fisher Scientific worth $273M as of Q1 2026.
Balyasny Asset Management bought 546,969 Thermo Fisher Scientific shares in Q1 2026, an estimated $297M.
Thermo Fisher Scientific made up 0.35% of Balyasny Asset Management's portfolio in Q1 2026, its #39 holding.
Balyasny Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 37 quarters since.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.